Current and historical daily PE Ratio for Alembic Pharmaceuticals Ltd (
BOM:533573
) from 2011 to Jun 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Alembic Pharmaceuticals stock (BOM:533573) PE ratio as of Jun 20 2024 is 26.97.
More Details
Alembic Pharmaceuticals Ltd (BOM:533573) PE Ratio (TTM) Chart
Alembic Pharmaceuticals Ltd (BOM:533573) PE Ratio (TTM) Historical Data
View and export this data going back to 2011. Start your Free Trial
Total 1244
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Alembic Pharmaceuticals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-21 | 27.0 | 2024-04-12 | 31.4 |
| 2024-06-20 | 27.0 | 2024-04-10 | 31.6 |
| 2024-06-19 | 27.5 | 2024-04-09 | 31.6 |
| 2024-06-18 | 27.7 | 2024-04-08 | 32.0 |
| 2024-06-14 | 28.4 | 2024-04-05 | 32.1 |
| 2024-06-13 | 28.2 | 2024-04-04 | 32.0 |
| 2024-06-12 | 28.5 | 2024-04-03 | 31.6 |
| 2024-06-11 | 28.6 | 2024-04-02 | 32.0 |
| 2024-06-10 | 29.0 | 2024-04-01 | 32.1 |
| 2024-06-07 | 29.2 | 2024-03-28 | 31.3 |
| 2024-06-06 | 28.5 | 2024-03-27 | 32.8 |
| 2024-06-05 | 28.5 | 2024-03-26 | 32.0 |
| 2024-06-04 | 27.7 | 2024-03-22 | 31.8 |
| 2024-06-03 | 29.3 | 2024-03-21 | 32.1 |
| 2024-05-31 | 29.4 | 2024-03-20 | 31.4 |
| 2024-05-29 | 30.2 | 2024-03-19 | 31.1 |
| 2024-05-28 | 30.0 | 2024-03-18 | 32.1 |
| 2024-05-27 | 30.2 | 2024-03-14 | 30.9 |
| 2024-05-24 | 30.3 | 2024-03-13 | 30.6 |
| 2024-05-23 | 30.6 | 2024-03-12 | 32.7 |
| 2024-05-22 | 30.4 | 2024-03-11 | 32.6 |
| 2024-05-21 | 30.3 | 2024-03-07 | 33.3 |
| 2024-05-17 | 30.6 | 2024-03-06 | 33.3 |
| 2024-05-16 | 30.9 | 2024-03-05 | 34.3 |
| 2024-05-15 | 31.0 | 2024-03-04 | 33.4 |
| 2024-05-14 | 30.8 | 2024-03-01 | 35.0 |
| 2024-05-13 | 30.4 | 2024-02-29 | 33.9 |
| 2024-05-10 | 31.1 | 2024-02-28 | 34.2 |
| 2024-05-09 | 32.0 | 2024-02-27 | 35.0 |
| 2024-05-08 | 32.0 | 2024-02-26 | 34.9 |
| 2024-05-07 | 32.7 | 2024-02-23 | 34.9 |
| 2024-05-06 | 32.6 | 2024-02-22 | 36.0 |
| 2024-05-03 | 32.7 | 2024-02-21 | 35.8 |
| 2024-05-02 | 31.7 | 2024-02-20 | 34.9 |
| 2024-04-30 | 31.8 | 2024-02-19 | 33.5 |
| 2024-04-29 | 31.8 | 2024-02-16 | 33.4 |
| 2024-04-26 | 31.6 | 2024-02-15 | 33.4 |
| 2024-04-25 | 31.8 | 2024-02-14 | 32.6 |
| 2024-04-24 | 30.3 | 2024-02-13 | 33.1 |
| 2024-04-23 | 30.0 | 2024-02-12 | 32.3 |
| 2024-04-22 | 30.1 | 2024-02-09 | 32.1 |
| 2024-04-19 | 29.9 | 2024-02-08 | 33.0 |
| 2024-04-18 | 29.7 | 2024-02-07 | 32.5 |
| 2024-04-16 | 30.8 | 2024-02-06 | 32.8 |
| 2024-04-15 | 30.9 | 2024-02-05 | 32.1 |
Alembic Pharmaceuticals Ltd (BOM:533573) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Alembic Pharmaceuticals Ltd
NAICS : 325412
ISIN : INE901L01018
Compare
Compare
Traded in other countries / regions
APLLTD.India IPO Date
2011-09-20Description
Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers